Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m 6 A-modified PTEN mRNA in pancreatic ductal adenocarcinoma

Dandan Zheng,Wenying Chen,Juanfei Peng,Xianxian Huang,Shineng Zhang,Yanyan Zhuang

DOI: https://doi.org/10.1038/s41417-024-00786-4

IF: 5.854

2024-05-28

Cancer Gene Therapy

Abstract:The role of circular RNAs (circRNAs) in glucose metabolism in pancreatic duct adenocarcinoma (PDAC) remains elusive. Through RNA sequencing of cells cultured under conditions of glucose deprivation, we identified hsa_circ_0007590. Sanger sequencing and RNase R and Act D treatments were performed to confirm the circular RNA features of hsa_circ_0007590. RNA in situ hybridization (RNA-ISH) and quantitative reverse transcription PCR (qRT-PCR) were used to estimate hsa_circ_0007590 expression in PDAC clinical specimens and cell lines. hsa_circ_0007590 expression was higher in PDAC patients and closely related to the clinicopathological characteristics of the disease. Cytoplasm‒nuclear fractionation and FISH assays demonstrated that hsa_circ_0007590 was located in the nucleus. Gain-of-function and loss-of-function assays were performed to assess the biological behaviors of PDAC cells. Seahorse XF assays were performed to validate the Warburg effect. hsa_circ_0007590 facilitated the proliferation, migration, and invasion of PDAC cells and promoted the Warburg effect. Mass spectrometry, RNA pulldown, RNA immunoprecipitation (RIP), RNA m 6 A quantification, m 6 A dot blot, MeRIP, and Western blotting were conducted to investigate the detailed mechanism through which hsa_circ_0007590 produces these effects. Mechanistically, hsa_circ_0007590 targeted PTBP1 and increased the expression of the m 6 A reader protein YTHDF2, leading to PTEN mRNA degradation and PI3K/AKT/mTOR pathway activation. Overall, hsa_circ_0007590, which targets PTBP1, reprograms glucose metabolism by attenuating the stability of m 6 A-modified PTEN mRNA and holds potential promise as a therapeutic target for PDAC.

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology